Search results
The Zacks Analyst Blog Highlights Biogen, Eli Lilly's, Prothena and AC Immune (Revised)
Zacks via Yahoo Finance· 5 hours agoOn Jun 10, the FDA’s Peripheral and Central Nervous System Drugs Advisory Committee (PCNS) voted...
Bristol Myers (BMY) Gets FDA Nod for Label Expansion of Augtyro
Zacks via Yahoo Finance· 3 hours agoThe FDA approves Bristol Myers' (BMY) cancer drug Augtyro for the treatment of adult and pediatric...
FDA warns consumers about paralytic shellfish poisoning in some contaminated shellfish
Consumer Affairs· 9 hours agoThe U.S. Food and Drug Administration (FDA) has issued a warning to restaurants and retailers to put...
Pharma Stock Roundup: FDA Panel Endorses LLY's Donanemab, PFE's DMD Therapy Study Fails
Zacks· 16 hours agoAn FDA panel endorses Eli Lilly's (LLY) Alzheimer's disease drug, donanemab. Pfizer's (PFE) DMD study on investigational gene therapy fails.
Novavax seeks FDA nod for updated COVID-19 vaccine By Investing.com
Investing.com· 2 hours agoNovavax , Inc. (NASDAQ: NASDAQ:NVAX) has announced its submission for an amended Emergency Use...
Legal Implications Following the FDA’s Release of Data on Talc-Containing Cosmetics, Which Confirm...
JD Supra· 10 hours agoIn April, the U.S. Food and Drug Administration (FDA) released the results of its 2023 sampling assignment, testing for asbestos in talc-containing products ...
FDA joins international push for transparency in AI development
FierceBiotech· 5 hours agoThe FDA is joining hands with regulators in Canada and the U.K. on policies to ensure transparency...
FDA took months to react to complaint about Abbott infant formula factory, audit finds
Associated Press Finance via Yahoo Finance· 1 day agoThe Department of Labor received the email and three days later forwarded it to an FDA address...
FDA advisers endorse Eli Lilly's early-stage Alzheimer's drug donanemab
News Channel Nebraska· 59 minutes agoBy Jen Christensen, CNN
Eli Lilly unveils new manufacturing plant for GLP-1 pens
Yahoo Finance· 22 minutes agoHernandez said the company built the Concord facility in two years, faster than the industry...